Marijuana’s classification under U.S. federal law has been a long-standing issue, debated across political, legal, and public health circles for decades. Its legal and medical status continues to divide opinions at both federal and state levels. Reclassification refers to changing how cannabis is categorized under drug control laws, which directly affects criminal penalties, medical access, and scientific research. Many experts argue that current classifications are outdated and don’t align with

Cannabis policy shifted worldwide—and culture helped tell the story. 🌍 From Germany’s booming legal market and pilot projects across Europe to U.S. federal rescheduling and global medical supply chains coming online, this rap recap by International Cannabis Business Conference captures a pivotal moment of progress. This piece is also created in honor of Peter Homberg, a true cannabis legend whose integrity, vision, and leadership helped shape the global industry. 💚 | Cannabis Now Magazine

What Trump's rescheduling of marijuana means for Michigan's cannabis industry, research